High proliferation is associated with inferior outcome in male breast cancer patients

Similarities and differences in the characteristics and primary treatment of breast cancer in men and women – a population based study (Sweden)

(2011) Cecilia Nilsson et al.   ACTA ONCOLOGICA

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

(2011) Elisabeth Luporsi et al.   BREAST CANCER RESEARCH AND TREATMENT

Incidence and Outcome of Male Breast Cancer: An International Population-Based Study

(2011) Hui Miao et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Value of Estrogen Receptor and Ki-67 Index after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Expressing High Levels of Proliferation at Diagnosis

(2011) L. Miglietta et al.   ONCOLOGY

Down-Regulation of the Oncogene Cyclin D1 Increases Migratory Capacity in Breast Cancer and Is Linked to Unfavorable Prognostic Features

(2010) Sophie Lehn et al.   AMERICAN JOURNAL OF PATHOLOGY

Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer

(2010) Maurizio Callari et al.   BREAST CANCER RESEARCH AND TREATMENT

High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer

(2010) Ida Johansson et al.   BREAST CANCER RESEARCH AND TREATMENT

Expression of cell cycle proteins in male breast carcinoma

(2010) Rani Kanthan et al.   World Journal of Surgical Oncology

Cyclin A Is a Proliferative Marker with Good Prognostic Value in Node-Negative Breast Cancer

(2009) C. Ahlin et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer

(2009) R. Agarwal et al.   CLINICAL CANCER RESEARCH

Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases

(2009) B. Cutuli et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer

(2008) Kirsimari Aaltonen et al.   BREAST CANCER RESEARCH AND TREATMENT

Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy

(2008) M. Rudas et al.   CLINICAL CANCER RESEARCH